Affiliation:
1. Department of Internal Medicine, University of Louisville Medical Center, Louisville, Kentucky 40292
Abstract
Alcoholic liver disease (ALD) remains a leading cause of death from liver disease in the United States for which there is no FDA-approved therapy. Abnormal cytokine metabolism is a major feature of ALD. Elevated serum concentration levels of TNF-α and TNF-α-inducible cytokines/chemokines, such as IL-6, -8, and -18, have been reported in patients with alcoholic hepatitis and/or cirrhosis, and levels correlated with markers of the acute phase response, liver function, and clinical outcome. Studies in animal models support an etiologic role for cytokines in the liver injury of ALD. Cytokines, such as transforming growth factor-β, play a critical role in the fibrosis of ALD. Multiple new strategies are under investigation to modulate cytokine metabolism as a form of therapy for ALD.
Publisher
American Physiological Society
Subject
Physiology (medical),Gastroenterology,Hepatology,Physiology
Reference30 articles.
1. Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor-α
2. Advances in alcoholic liver disease
3. Cabre E, Rodriguez-Iglesias P, Caballeria J, Quer JC, Sanchez-Lombrana JL, Pares A, Papo M, Planas R, Gassull MA, and the Spanish Group for the Study of Alcoholic Hepatitis. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 32: 36–42, 2000.
4. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression
5. TNF-R1 Signaling: A Beautiful Pathway
Cited by
210 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献